Asia Pacific Primary Care Poc Diagnostics Market Size & Outlook
Asia Pacific primary care poc diagnostics market, 2018-2030 (US$M)
Asia Pacific primary care poc diagnostics market highlights
- The Asia Pacific primary care poc diagnostics market generated a revenue of USD 3,430.6 million in 2023.
- The market is expected to grow at a CAGR of 8.2% from 2024 to 2030.
- In terms of segment, pharmacy & retail clinics was the largest revenue generating end use in 2023.
- Pharmacy & Retail Clinics is the most lucrative end use segment registering the fastest growth during the forecast period.
Asia Pacific data book summary
| Market revenue in 2023 | USD 3,430.6 million |
| Market revenue in 2030 | USD 5,953.7 million |
| Growth rate | 8.2% (CAGR from 2023 to 2030) |
| Largest segment | Pharmacy & retail clinics |
| Fastest growing segment | Pharmacy & Retail Clinics |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pharmacy & Retail Clinics |
| Key market players worldwide | Roche Holding AG ADR, BD, Danaher Corp, Abbott Laboratories, BioMerieux SA, Siemens Healthineers AG ADR, QuidelOrtho Corp, Thermo Fisher Scientific Inc |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 20.4% of the global primary care poc diagnostics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 5,953.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Primary Care POC Diagnostics Market Scope
Primary Care POC Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific primary care poc diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to primary care poc diagnostics market will help companies and investors design strategic landscapes.
Pharmacy & retail clinics was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Asia Pacific primary care poc diagnostics market based on pharmacy & retail clinics covering the revenue growth of each sub-segment from 2018 to 2030.
Point of care tests is gaining rapid adoption attributive to associated advantages with its usage which include fast, easy and mobile diagnosis and self-monitoring. These products offer diagnosis and monitoring for patients at hospitals, health assessment centers, clinics, home healthcare.
Development of healthcare infrastructure coupled with higher prevalence of chronic and targeted diseases like diabetes and cancer along with infectious conditions including HIV, syphilis, RSV, and others are expected to drive the market in Asia Pacific countries.
Furthermore, rise in adoption of miniaturized models and measures taken for reduction in stay at hospitals and clinics are expected to fuel the demand for POC products. Adoption of POC diagnostics in operation theaters, emergency rooms, intensive care units, path labs and hospitals is expected to rise owing to the early and efficient results.
Reasons to subscribe to Asia Pacific primary care poc diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific primary care poc diagnostics market databook
-
Our clientele includes a mix of primary care poc diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific primary care poc diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific primary care poc diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific primary care poc diagnostics market
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
